Correcting the ASCO position on phase I clinical trials in cancer
Correcting the ASCO position on phase I clinical trials in cancer
Related Articles
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Cellular senescence accumulates with age and has been shown to impact numerous physiological and pathological processes, including immune function. The role of cellular senescence in…
Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) are employed in immunotherapeutic applications for patients with weakened immune systems and can improve the ability of T cells to kill…
Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care
Nature Reviews Clinical Oncology – Patients receiving cytotoxic therapies for cancer have an increased risk of cognitive and functional decline that is usually associated with…
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review
Cellular therapies, including autologous stem cell transplant (ASCT), allogeneic hematopoietic cell transplantation (alloHCT), and chimeric antigen receptor- (CAR-) T cell therapies are essential treatment modalities…
IMPACT OF AGE, FRAILTY AND COMORBIDITIES IN THE SURVIVAL OF OLDER… by Raul Cordoba
EHA Library; Cordoba R. Jun 14 2025; 4160933;
Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective
While Bruton’s tyrosine kinase inhibitors (BTKis) have prolonged survival for patients with chronic lymphocytic leukemia (CLL), continuous administration can increase physical, emotional, and financial toxicity1-3.…
IO, Melanoma, GeriOnc & Heme: OncoAlert Colloquium
ORDER OF SPEAKERSImmunotherapyDr. John Haanen of Netherlands Cancer Institute, NetherlandsMelanoma Dr. Allison Betof Warner of Stanford Medicine, USASIOG Ses…
El presidente electo de la SEHH reivindica la medicina de precisión…
El presidente electo de la Sociedad Española de Hematología y Hemoterapia (SEHH) y presidente del Grupo…
Prognostic Relevance and Lower Limit of the Reference Range of Left Ventricular Global Longitudinal Strain: A Clinical Validation Study
AbstractBackgroundThe lower limit of the reference normal range (LLN) of left ventricular global longitudinal strain (GLS) for each ultrasound software vendor and its prognostic relevance…
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review
Key PointsIn phase 3 lymphoma randomized trials, definitions of bulk and its use in the design vary significantly across and within disease subtypes.Of 87